• Home
  • MF Research
  • ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option

ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option

arrow-up
NAV
₹ 16.4114 ₹ 0.02 (0.15 %)
as on 11-07-2025
Asset Size (AUM)
219 Cr
Launch Date
Nov 08, 2021
Investment Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
Minimum Investment 5000.0
Minimum Top-up 1000.0
Investment Returns Since Launch in Nov 08, 2021
arrow-up

14.44

%
3 M
6 M
1 Y
3 Y
10 Y
Inception
Sharp Ratio
N/A
Expense Ratio
2.35%
Volatility
N/A
Fund House
ITI Mutual Fund
Fund Manager
Mr. Dhimant Shah, Mr. Rohan Korde, Mr. Rajesh Bhatia
Key Features
Scheme description
Minimum Purchase Application Amount
Rs. 5000.0 (plus in multiples of Rs. 1000.0)

Entry Load
Not applicable
Exit Load
1% if redeemed or switched out on or before completion of 12 months from the date of allotment of units. Nil, if redeemed or switched out after completion of 12 months from the date of allotment of units.
Indicative Investment Horizon
5 Years and above
Asset Allocation
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4AssetsCash & Cash EquivalentsEquity
Fund Performance
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4FundFDGoldNifty
Fund₹ 11176
FD₹ 10600
Gold₹ 10800
Nifty₹ 11176
Performance

Scheme Performance (%)

Data as on - 11-07-2025
Created with Highcharts 4.1.4ReturnsITI Pharma and Healthcare Fund - Regular Plan - IDCW OptionNIFTY Healthcare TRIEquity: Sectoral-Pharma and HealthcareYTD1 Month3 Month6 Month1 Year3 Years5 Years10 YearsSince Launch-100102030

Yearly Performance (%)

Created with Highcharts 4.1.4ValuesITI Pharma and Healthcare Fund - Regular Plan - IDCW OptionNIFTY Healthcare TRIEquity: Sectoral-Pharma and Healthcare2016201720182019202020212022202320242025-20020406080
Investment Returns Calculator
Amount InvestedFund ValueProfitReturns
Fund120,000121,7511,7513.18
Benchmark120,000123,8013,8016.96
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Peer Comparison
Scheme Name Inception Date 1 Year Return % 2 Year Return % 3 Year Return % 5 Year Return % 10 Year Return %
ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option 08-11-2021 11.76 25.47 22.51 0.0 0.0
HDFC Pharma and Healthcare Fund - Growth Option 04-10-2023 24.88 0.0 0.0 0.0 0.0
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 06-02-2024 22.69 0.0 0.0 0.0 0.0
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 17.7 28.16 28.12 23.95 11.59
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 17.59 34.11 28.86 24.42 0.0
Portfolio Analysis
Portfolio as on 31-05-2025
Sector Allocation
SectorAllocation (%)
Healthcare93.52
Chemicals4.57
Information Technology1.29
Diversified0.32
Portfolio Holdings
CompanyHoldings (%)
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-15.18
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-9.120000000000001
MAX HEALTHCARE INSTITUTE LIMITED EQ5.42
LUPIN LIMITED EQ NEW F.V. RS.2/-5.4
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-5.19
SUVEN PHARMACEUTICALS LIMITED EQ4.84
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-3.93
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-3.91
ASTER DM HEALTHCARE LIMITED EQ3.15
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/-3.04
ALKEM LABORATORIES LIMITED EQ2.87
FORTIS HEALTHCARE LIMITED. EQ2.4299999999999997
ABBOTT INDIA LIMITED EQ2.33
WOCKHARDT LIMITED EQ FV RS. 5/-2.2800000000000002
GRANULES INDIA LIMITED EQ NEW FV RE. 1/-2.11
NEULAND LABORATORIES LIMITED EQ1.9800000000000002
FDC LIMITED EQ FV RE 1/-1.55
HEALTHCARE GLOBAL ENTERPRISES LTD EQ1.55
SUPRIYA LIFESCIENCE LIMITED EQ1.48
SUMITOMO CHEMICAL INDIA LIMITED EQ1.43
SAGILITY INDIA PRIVATE LIMITED EQ1.29
RAINBOW CHILDRENS MEDICARE LIMITED EQ1.28
JB Chemicals & Pharmaceuticals Limited1.23
VIJAYA DIAGNOSTIC CENTRE LIMITED EQ NEW FV Re.1/-1.23
SHILPA MEDICARE LIMITED EQ NEW FV RE. 1/-1.22
Dr. Reddys Laboratories Ltd1.22
GLAND PHARMA LIMITED EQ NEW FV Re.1/-1.18
GLAXOSMITHKLINE PHARMACEUTICALS LTD EQ1.18
UPL LIMITED EQ NEW FV RS.2/-1.1400000000000001
STELIS BIOPHARMA LIMITED EQ NEW FV RE.1/-1.09
CAPLIN POINT LABORATORIES LIMITED EQ NEW FV RS. 2/-1.08
LINDE INDIA LIMITED EQ1.0699999999999998
ORCHID PHARMA LIMITED EQ NEW FV RS. 10/-1.03
CIPLA LIMITED EQ NEW FV RS.2/-1.02
Sai Life Sciences Limited1.02
STRIDES PHARMA SCIENCE LIMITED EQ1.01
LAURUS LABS LIMITED EQ NEW FV RS. 2/-0.97
SRF LIMITED EQ0.9299999999999999
TTK HEALTHCARE LIMITED EQ0.32
Net Receivables / (Payables)0.3
Sector Allocation
Created with Highcharts 4.1.4HealthcareChemicalsInformation TechnologyOthers
Portfolio Holdings
Created with Highcharts 4.1.4SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-MAX HEALTHCARE INSTITUTE LIMITED EQLUPIN LIMITED EQ NEW F.V. RS.2/-APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-SUVEN PHARMACEUTICALS LIMITED EQAUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-ASTER DM HEALTHCARE LIMITED EQOthers